To assess the clinical relevance of the NRF2-mediated glutathione metabolic shift in OAC primary tumours, we used GCLM, GCLC, GSR transcript levels to calculate the risk score based on datasets from The Cancer Genome Atlas (TCGA). The gene discussed is NFE2L2; the disease is neoplasm.